价格

antibody drug conjugate targeting HER2

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

METHOD FOR PREPARING HER2 NANOBODY AND CONJUGATE, AND USE THEREOF
US 20260151496 A1申请人: UNIV FUDAN优先权: 2022
CN
EP
US
WO
6 件公开
USE OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN TREATMENT OF SPECIFIC BREAST CANCER
US 2024148894 A1申请人: REMEGEN CO LTD优先权: 2021
CN
EP
US
WO
4 件公开
USE OF ANTIBODY-DRUG CONJUGATE IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR IN TREATMENT OF UROTHELIAL CANCER
US 2024207431 A1申请人: REMEGEN CO LTD优先权: 2021
CN
EP
US
WO
4 件公开
USE OF HER2-TARGETING ANTIBODY-DRUG CONJUGATE IN TREATMENT OF HER2-LOW EXPRESSING BREAST CANCER
US 2024207424 A1申请人: REMEGEN CO LTD优先权: 2021
CN
EP
US
WO
4 件公开
ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF
EP 4386006 A4申请人: JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD优先权: 2021
CN
EP
US
WO
4 件公开
ANTI-HER2 ANTIBODY-IMMUNE AGONIST CONJUGATE AND APPLICATIONS THEREOF
EP 4304661 A1申请人: GENEQUANTUM HEALTHCARE SUZHOU CO LTD优先权: 2021
EP
US
WO
3 件公开
ANTIBODY-DRUG CONJUGATE AND USE THEREOF
EP 4434549 A1申请人: CSPC MEGALITH BIOPHARMACEUTICAL CO LTD优先权: 2021
EP
US
2 件公开
METHODS FOR THE DETECTION AND TREATMENT OF RESISTANT CANCERS CO-EXPRESSING ALPP AND/OR ALPG/ALPPL2
EP 4801949 A1申请人: UNIV TEXAS优先权: 2023
EP
WO
2 件公开
USE OF ADC TARGETING HER2 IN TREATMENT OF BREAST CANCER
WO 2025131036 A1申请人: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD优先权: 2023
CN
WO
2 件公开
BISPECIFIC ANTIBODY TARGETING EGFR AND HER2 AND ANTIBODY-DRUG CONJUGATE
WO 2025237380 A1申请人: CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD优先权: 2024
CN
WO
2 件公开

药物